Biosimilars Council @BiosimsCouncil
Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ… biosimilarscouncil.org Washington, DC Joined July 2015-
Tweets3K
-
Followers10K
-
Following1K
-
Likes2K
The Biosimilars Council continues to dig into FDAs Q&A Draft Promotional Labeling Guidance and we agree: "Once FDA licenses a biosimilar product, including an interchangeable #biosimilar product, HCPs and patients can be confident of the safety and effectiveness of the biosimilar…
The Biosimilars Council continues to dig into FDAs Q&A Draft Promotional Labeling Guidance and we agree: "Once FDA licenses a biosimilar product, including an interchangeable #biosimilar product, HCPs and patients can be confident of the safety and effectiveness of the biosimilar…
The @FDA approved the 50th #biosimilar this week. Congratulations from the Biosimilars Council and the Association for Accessible Medicines and thank you for your hard work and dedication to safe and effective biosimilars medicines. "The FDA is committed to the continued…
“The Biosimilars Council commends FDA for its continued work to educate on the safety and efficacy of biosimilars and interchangeables. The draft guidance is an important step in the ongoing work to combat brand pharma misinformation campaigns. As FDA makes clear, ‘Biosimilars…
Patients' decisions on biosimilar products are heavily influenced by insurance coverage and potential out-of-pocket costs. Gain further insights: bit.ly/3VYOrgd. #Biosimilars #PharmaSpending
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why? Avalere analysis finds Part D prescription drug plans continue to increase patient copays for generics by moving them to higher tiers. Despite years of demonstrated savings and price…
Payers continue to block patient access to #biosimilars, denying 2/3 of prescriptions for biosimilar Humira. Craig Burton, Executive Director of the Biosimilars Council shared this and more at the 2024 Festival of Biologics. @festofbiologics @jcraigburton
Giuseppe Randazzo, SVP of Sciences & Regulatory Affairs at AAM, will be moderating and chairing sessions today at the 2024 Festival of Biologics in San Diego. He’ll be leading discussions on the regulatory landscape for #biosimilars and advocacy best practices to ultimately help…
#festivalofbiologicsusa is underway! Barry Chester (@pfizer) opens our 2024 edition with a discussion around Biosimilars and the ‘Challenges of Achieving Sustainbability in an Evolving Landscape’ Bring on day 1!
FDA is ready to eliminate the interchangeability designation for biosimilars via Endpoints News Sarah Yim, director of the FDA’s Office of Therapeutic Biologics and Biosimilars, said the FDA wants to make all biosimilars interchangeable with a legislative proposal that would…
FDA is ready to eliminate the interchangeability designation for biosimilars via Endpoints News Sarah Yim, director of the FDA’s Office of Therapeutic Biologics and Biosimilars, said the FDA wants to make all biosimilars interchangeable with a legislative proposal that would…
Craig Burton, Executive Director of the Biosimilars Council, will be presenting at the 2024 Festival of Biologics in San Diego today. #Biosimilars have saved over $23b since 2015. Biosimilars are delivering savings and expanding #patient access. @festofbiologics @jcraigburton
Monday marks the day we've all been waiting for – Festival of Biologics San Diego! 🌟 Get ready to dive into a day packed with inspiration, networking, and valuable insights. Don't forget to register and get your pass👉bit.ly/3ub2Iuz
“The biggest shortages are occurring in inexpensive generic drugs where the less expensive the drug, the more likelihood of shortage because of the way the market is not succeeding in rewarding high-quality manufacturing,” FDA Commissioner Robert Califf before the House Oversight…
The U.S. need a robust, sustainable & predictable #generic and #biosimilar medicines marketplace. From @axios Vitals: Drug shortages reach all-time high "Why it matters: This high-water mark should energize efforts in Congress and federal agencies to address the broken market…
AAM General Counsel Karin Hessler will be on Capitol Hill today to discuss patents and #patent reform and the impact on patients' ability to get the #generic and #biosimilar medicines they need. Thank you to R Street for hosting today's discussion on patent policy. @RSI
AAM General Counsel Karin Hessler will be on Capitol Hill today to discuss patents and #patent reform and the impact on patients' ability to get the #generic and #biosimilar medicines they need. Thank you to R Street for hosting today's discussion on patent policy. @RSI
🧬 Exciting news! The Festival of Biologics is just around the corner. Join us for three days of cutting-edge science, networking, and game-changing breakthroughs. 🌟 @festofbiologics 🗓️ April 15–17, 2024 📍 San Diego Convention Center 👉 terrapinn.com/conference/fes…
Craig Burton, the executive director of the @BiosimsCouncil, an advocacy group, told Endpoints News the market share data was more proof of the “stranglehold” PBMs have on prescribing. The dynamics with Humira “could serve as a model for blocking future biosimilars unless…
AJMC @BiosimCenter: Meta-Analysis Confirms Similar Safety, Efficacy Between Humira & Adalimumab #Biosimilars centerforbiosimilars.com/view/meta-anal…
Study finds biosimilar competition doesn't always translate to lower out-of-pocket costs for patients with commercial insurance, highlighting need for policy changes. #Biosimilars Read More: bit.ly/3VIDAH2
“This is just one more sad reminder of the challenges that lower-priced biosimilars have encountered due to PBM choices to continue covering Humira. It is critical that policymakers act now to end PBM abuses and to ensure a long-term sustainable biosimilars market.” - Craig…
“This is just one more sad reminder of the challenges that lower-priced biosimilars have encountered due to PBM choices to continue covering Humira. It is critical that policymakers act now to end PBM abuses and to ensure a long-term sustainable biosimilars market.” - Craig…
“This is just one more sad reminder of the challenges that lower-priced biosimilars have encountered due to PBM choices to continue covering Humira. It is critical that policymakers act now to end PBM abuses and to ensure a long-term sustainable biosimilars market.” - Craig…
“This is just one more sad reminder of the challenges that lower-priced biosimilars have encountered due to PBM choices to continue covering Humira. It is critical that policymakers act now to end PBM abuses and to ensure a long-term sustainable biosimilars market.” - Craig…
Zach Brennan @ZacharyBrennan
10K Followers 1K Following Senior Editor, Endpoints News - covering the FDA, Capitol Hill, regulatory policy, and all things biotech/pharma - reach me at [email protected]
Sarah Karlin-Smith @SarahKarlin
17K Followers 3K Following Covering intersection of pharma, policy & politics for @pharmapinksheet. @smpagwu adjunct Past @politico. Inflexible Yogi, Volunteer Clown. @amaxsmith fan.
AAM @AccessibleMeds
13K Followers 2K Following Association for Accessible Medicines promotes policies to ensure generic & biosimilar medicines are accessible to people who need them.
Samsung Bioepis @SamsungBioepis
31K Followers 233 Following We make high quality biologic medicines more accessible, more quickly. See our community guidelines: https://t.co/VDDbzPMJvF. #InnovatingAccess
BioSim @BioSim_es
5K Followers 2K Following Asociación Española de Medicamentos Biosimilares Queremos dar a conocer el valor de los Biosimilares en el sistema sanitario 💚 💼LinkedIn 📹YouTube 📱Instagram
Encarna Cruz Martos @EncarnaCruzM
401 Followers 92 Following Directora General de Biosim. Apasionada de los medicamentos. Las opiniones vertidas en este perfil son exclusivamente personales.
Madelaine Feldman @MattieRheumMD
3K Followers 2K Following All opinions are my own and do not reflect those of CSRO-Rheumatologist, Lecture on PBMs, & their part in drug access & pricing-Passion still ahead of cynicism
Biosimilars Canada | .. @CDNBiosimilars
441 Followers 292 Following The voice of biosimilar medicines in Canada. La voix des médicaments biosimilaires au Canada. A division of @cdngenerics.
Adam Gladieux @adam_gladieux
1K Followers 2K Following Founder and CEO @rx_rise 🚀 Dad, Husband, Former College Basketball Player, EY Entrepreneur of the Year - Southeast Finalist 2023
Mike @25FLBuckeye
23 Followers 173 Following
Kati Sarnola @KatiSarnola
407 Followers 664 Following Erikoistutkija, dosentti @Kelantutkimus @KelaFpa. Työpöydällä mm. #lääkkeet, #kustannukset, #kustannusvaikuttavuus, #saatavuus ja #työkyky. Twiitit omia.
Gísli Halldórsson @gislih
294 Followers 770 Following Equity Fund Manager at IS Funds. Finance and sport enthusiast.
Lainey Nix @lainey_nix
133 Followers 141 Following
Festival of Biologics @festofbiologics
62 Followers 73 Following The start-to-finish of biologics; drug discovery, development, clinical trials, manufacturing, pricing & market access.
Vibha Ravi @scripvibha
665 Followers 614 Following Senior Editor, Citeline - Scrip, Pink Sheet. Tweets on pharma, health, environment, other topics of interest to those who read beyond headlines, social media
John McCoy @JohnMcCoy128318
109 Followers 164 Following
Nabil Quraishi @NabilQuraishi
1K Followers 1K Following 🇦🇪🇬🇧Gastroenterologist - IBD, microbiome therapies, QI @SSMCAbuDhabi @unibirmingham @beggs_lab @UoBMicrobiomeTC
Lawson Mansell @lawsonhmansell
671 Followers 908 Following health policy @niskanencenter | MPP @pepperdinespp | 🌙 south carolina native 🌴 | pittsburgh sports | @usmnt apologist
L u c e sn e g r a s @lucesnegras_
362 Followers 676 Following XXX. Trabajo con sustancias controladas y materiales radioactivos.
Nordic Capital @davste86
373 Followers 1K Following Here for FinTwit. Currently PE Principal. Previously multi-strategy fund manager, M&A & restructuring.
Joe @jnemuras
1 Followers 563 Following
Vishala Mishra @vishala_mishra
266 Followers 3K Following Physician and Clinical Informaticist interested in using data for health equity.
ohn4d8bdmuz @zx735s1kquuxq7
14 Followers 251 Following If you want to make friends, you can contact me anytime TG：https://t.co/PEMo2cy1u2 WS：https://t.co/wNr6sndmSP
Mina Amin @Minayia152421
16 Followers 187 Following Business Development and Lead Generation specialised in: ▪︎Niche #Biosimilar and #Generics ▪︎#Medical_Devices ▪︎#Medical_Consumables
Darbin Wofford @darbin_w
327 Followers 734 Following Senior Health Policy Advisor @ThirdWayEcon 🩺💊🏥 📉| Leading Fixing America’s Broken Hospitals | @GSPMgwu alumni | Occasional NFL takes | Views are my own.
Aditya Agarwal @AdsAgarwal
36 Followers 98 Following
Riyadh | Health @Riyadh1Health
199 Followers 3K Following #secure in your property, #healthy body, & day #food, it is as if the whole world were brought to you. — Riyadh (on #X since 2008) Old clinic owner.
BioL-BioS 2024 @BioLBioS2024
3 Followers 321 Following 5th Euro-Global Summit on Future of Biologics and Biosimilars
Håkan Yildirim @HkanYildirim
10 Followers 89 Following Head of Intellectual Property at Xbrane Biopharma AB. European Patent Attorney & Litigator. Former patent examiner. Doctorate in chemistry.
lexon @lexon3333
166 Followers 1K Following
LearnReg @LearnReg
11 Followers 32 Following Pharmaceutical News, updates, Training courses, Biological
Nitish Singhal @NitishS89750733
1 Followers 68 Following
Cheekyhants @cheekyhants
346 Followers 2K Following lifes too short...live each day with a smile and have some fun!! Love Science, love Biology, love dogs.
Usha Narayan @NarayanUsha
11 Followers 94 Following Scientist and Business Devevelopment professional keen to see changes in the healthcare in India
GLP-1 News @GLP1_News
261 Followers 90 Following Stay in the know with your #1 source for all things GLP-1. #Mounjaro #Ozempic #Rybelsus #Saxenda #Trulicity #Victoza #Wegovy #Zepbound #GLP1 #releasethevials
niall hopkins @niall_hopkins
2 Followers 234 Following
htaAlerts @htaAlerts
2K Followers 2K Following Health Technology Assessment alerts including the socioeconomic impact of new healthcare technologies in society. Content curated by @Syenza_Corp
Menaga @MenagaSN
19 Followers 33 Following
Adrian van den Hoven @AdrianMEDSforEU
630 Followers 261 Following Director General @medicinesforEU #patients #quality #value #sustainability #partnership RTs not endorsement
RL Meighan-Mantha @SeduloGrpRachel
0 Followers 7 Following
Noor Saade @NoorSaade961
0 Followers 67 Following
Capital Rx @cap_rx
477 Followers 96 Following Our mission is to advance our nation's healthcare infrastructure to improve drug price visibility and patient outcomes and deliver the care we deserve.
isaac777NFT @IsaacCiuMe
57 Followers 167 Following The world is changing…🔺#NFT #Splinterlands💎I am in love #Runi 1656
Syed Adeel Ahmed @syedahmedadeel
2K Followers 3K Following life-science professional • faith, friends, love, eat & drink and be kind to everyone
l2ich.LP @RichardPol91859
72 Followers 252 Following
richard @richard51520393
73 Followers 135 Following
Convergence Metals @CMGmotivation
39 Followers 210 Following
Biosimilar Today iMag.. @BiosimilarToday
549 Followers 1K Following La revista online de referencia en biosimilares, farmacia hospitalaria, oncología, hematología, reumatología y gastroenterología. #biosimilar
iStacks @iSatcks
16 Followers 38 Following We scale brands profitably online using multi-channel, data-driven advertising. Scale with the experts
phoebe velez @feebsworkfeed
0 Followers 19 Following
Allawy @Allawy_egibra
57 Followers 753 Following
Melanie Salter @MelSalterPharmD
38 Followers 404 Following Immunology MSL | Loves medicine, learning, hiking, cooking, and my dog
Dr Rajan Dubey 🥇 @drrajandubey
388 Followers 2K Following Farmer, public health activist, student of India, writer, father and son.... All in a small journey of love
Adam J. Fein @DrugChannels
18K Followers 4 Following Expert insights from Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system. Contact me at [email protected]
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Zach Brennan @ZacharyBrennan
10K Followers 1K Following Senior Editor, Endpoints News - covering the FDA, Capitol Hill, regulatory policy, and all things biotech/pharma - reach me at [email protected]
Sarah Karlin-Smith @SarahKarlin
17K Followers 3K Following Covering intersection of pharma, policy & politics for @pharmapinksheet. @smpagwu adjunct Past @politico. Inflexible Yogi, Volunteer Clown. @amaxsmith fan.
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
AAM @AccessibleMeds
13K Followers 2K Following Association for Accessible Medicines promotes policies to ensure generic & biosimilar medicines are accessible to people who need them.
Alexander Gaffney @AlecGaffney
7K Followers 940 Following Executive Director, Regulatory Policy & Intelligence @Politico's @AgencyIQ. Tweeting about @US_FDA's regulation of #Pharma, #MedicalDevice, #Biotech & #Health.
Samsung Bioepis @SamsungBioepis
31K Followers 233 Following We make high quality biologic medicines more accessible, more quickly. See our community guidelines: https://t.co/VDDbzPMJvF. #InnovatingAccess
Scott Gottlieb, MD @ScottGottliebMD
575K Followers 2K Following Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd @US_FDA Commissioner. Boards: @Pfizer @Illumina @AetionInc @TempusAI @IncResilience @ComancheBio Xaira
NCPA @Commpharmacy
24K Followers 3K Following NCPA represents over 19,400 pharmacies that employ 230,000+ folks nationwide. Community pharmacists are among America’s most accessible health care providers.
BioSim @BioSim_es
5K Followers 2K Following Asociación Española de Medicamentos Biosimilares Queremos dar a conocer el valor de los Biosimilares en el sistema sanitario 💚 💼LinkedIn 📹YouTube 📱Instagram
Luke Timmerman @ldtimmerman
35K Followers 231 Following Biotech Journalist. Founder @TimmermanReport. Mountaineer. Volunteer. @LS_Cares @DamonRunyon
Encarna Cruz Martos @EncarnaCruzM
401 Followers 92 Following Directora General de Biosim. Apasionada de los medicamentos. Las opiniones vertidas en este perfil son exclusivamente personales.
Kate Bennett @KateBennett_DC
100K Followers 1K Following Senior Advisor @INVARIANT. Strategic/crisis communications/public affairs. Prev @CNN White House correspondent. I was once a fashion editor, trust me.
Jessica Merrill @Jessicaemerrill
3K Followers 346 Following biopharma reporter, writer, reader, vermonter, mom.
Bob Herman @bobjherman
21K Followers 4K Following Health care business reporter for @statnews and its Health Care Inc. newsletter. Contact: [email protected] or DM.
Madelaine Feldman @MattieRheumMD
3K Followers 2K Following All opinions are my own and do not reflect those of CSRO-Rheumatologist, Lecture on PBMs, & their part in drug access & pricing-Passion still ahead of cynicism
David Mitchell @DavidP4AD
5K Followers 1K Following Diagnosed w/multiple myeloma 2010. Completely dependent on innovation & new drugs for survival. Fighting for affordable prices. Founder: @P4AD_ & @P4ADNOW
Biosimilars Canada | .. @CDNBiosimilars
441 Followers 292 Following The voice of biosimilar medicines in Canada. La voix des médicaments biosimilaires au Canada. A division of @cdngenerics.
Tony Hagen @OncoBiz
439 Followers 545 Following Tony Hagen is a senior editor with MJH Life Sciences. He covers biosimilars for AJMC/The Center for Biosimilars.
We Work For Health @weworkforhealth
1K Followers 968 Following Bringing together stakeholders to preserve America’s leadership in the life sciences
Festival of Biologics @festofbiologics
62 Followers 73 Following The start-to-finish of biologics; drug discovery, development, clinical trials, manufacturing, pricing & market access.
Duffy Glaser @duffglaser
6K Followers 1K Following Sr.Executive #Healthcare Enterprise Software #ACA,#turnaroundexpert #nochildhungry. Foodie/Father/BU/Harvard and most of all a Choatie #Forevertrueblueandgold
IGBA @IGBAmedicines
42 Followers 76 Following International Generic and Biosimilar medicines Association. IGBA works to improve global patient access to quality-assured, safe and cost-effective medicines.
4GRxANTED @4grxanted
54 Followers 29 Following Every like, comment and share of a #4GRxANTED video will result in donations of medicine to underserved patients through @DirectRelief. #genericsindustry
Mark Cuban @mcuban
8.8M Followers 2K Following Dunking on the pharma industry with @costplusdrugs.com, the lowest prices on meds anywhere. check it out !
Julie Maréchal-Jamil @Julie_MarJam
185 Followers 408 Following Learnatic - Enthusiastic Believer - Greater Good is Within Reach - Pharma, Brain&Body connection - @medicinesforEU. Views my own. Retweets≠endorsement
Kristin Willemsen @kwistin093
614 Followers 964 Following Vice President, Scientific & Regulatory Affairs at the Canadian Generic Pharmaceutical Association, Certified Association Executive. Mother. Views are my own.
RGC @NotoriousRGC
502 Followers 560 Following Healthcare Public Affairs Pro; #DOC T1D since 2003, T1D Advocate, DIY Looping, NY 2 DC, Opinions my own
Lachman Consultants @LachmanConsult
79 Followers 70 Following Global Compliance, Regulatory, and Science & Technology Consulting. Experience Excellence with Lachman Consultant Services, Inc.
Nicolas Ferreyros @nickcf
1K Followers 1K Following Advocate. Wonk. Communicator. Managing Director @OncologyCOA. Tweets are personal views & RTs/likes are not endorsements (but I would be flattered if you cared)
Neil Grubert @NeilGrubert
262 Followers 27 Following Independent pharmaceutical consultant, trainer and writer with a focus on pricing, reimbursement and market access trends around the world
Ameet Sarpatwari @AmeetSarpatwari
2K Followers 823 Following Epidemiologist-Lawyer; Assistant Professor of Medicine, Brigham and Women's Hospital/Harvard Medical School; JD-MPH Director, Harvard School of Public Health
Kimberly Westrich @Kim_Westrich
1K Followers 1K Following Value & Access Strategy / Optimalist / Life Coach / Yoga Instructor / Marathoner / Chief Possibility Officer @1Kimpossibility
Anne Marie Mercurio @chemobrainfog
13K Followers 5K Following Patient research advocate. #SWOG PAC co-chair, BreastCancer NED 2007, #Caregiver #Medidata Patient Insights Board FD: https://t.co/SDGi78y43y
Tina Aswani-Omprakash.. @ownyourcrohns
5K Followers 2K Following #IBD #Ostomy Patient Advocate • Senior Director, Strategic Partnerships @sommerconsults @theinsighters_ • President @southasianibd @ibdesis
Ready for Cures @ReadyForCures
284 Followers 681 Following Improving access to life-saving medicines. Fostering a public policy environment that supports healthcare innovation. #ReadyforCures https://t.co/IcKBOzqnLu
Xcenda @Xcenda
653 Followers 45 Following Xcenda, a part of Cencora (formerly AmerisourceBergen), helps biopharma in showcasing value to global healthcare stakeholders with lifecycle solutions.
Dr Richard Jähnke @GPHF
30K Followers 26K Following The Global Pharma Health Fund (GPHF) is a charity working to combat falsified and poor-quality medicines in developing countries. Funded by Merck KGaA.
Act4Biosimilars @Act4Biosimilars
100 Followers 17 Following A global initiative to improve patient access to biologic medicines through increased #biosimilar uptake. Guidelines: https://t.co/tUP5OYe8z4
Shayla Love @shayla__love
12K Followers 4K Following Journalist writing about science, health, and mind. [email protected]
IQVIA Institute @IQVIA_Institute
4K Followers 1K Following The #IQVIAInstitute uses #HumanDataScience to look at how we can evaluate, enable and advance human health through a new, evidence-based lens.
Tricia Busch @triciaebusch
398 Followers 2K Following health care PR at Salutem @edelmanPR | fmr: @_achp @teamkivvit | views my own. rt≠endorsement. | she/her
Dr. Robert M. Califf @DrCaliff_FDA
11K Followers 43 Following Husband, father, grandfather. Doctor with heart(s). Commissioner of Food and Drugs - @US_FDA
Vincent Rajkumar @VincentRK
81K Followers 2K Following Editor-in-Chief, Blood Cancer Journal; Oncologist; Cancer Research; Opinions are solely my personal views https://t.co/HOGYJSpsoG
kristi martin @RunawayWonk
317 Followers 552 Following Just a policy wonk fighting for access to affordable healthcare and Rx drugs for all. Being “in the weeds” is my happy place. All opinions are mine.
Biosimilars & Biologi.. @Biosimilars2020
53 Followers 303 Following
David M. Dudzinski MD.. @criticalecho
1K Followers 173 Following Critical care cardiologist, #CICU director, echocardiographer. Attorney interested in #biosimilars #ethics #liability. Dad of 3. @nejmcpc @mghecho @mghhcicu #PE
Biosimilars @Biosimilars13
342 Followers 1K Following Biosimilars 2018 anticipates large number of participants around the globe. For details contact us at: [email protected]
Biosimilars USA @BiosimilarsUSA
427 Followers 1 Following Latest news on biosimilars and the biotech industry
safebiologics.org @SAFEbiologics
730 Followers 1K Following We're a non-profit org of patients, physicians, & biotech cos. working to ensure patient safety = the forefront of #biosimilars policy. #healthcare #biologics
RSI Biosimilars @Biosimilars_RSI
141 Followers 45 Following
Biosimilars Today @biolguy
156 Followers 127 Following Head of Business Development -- Personal views on biosimilars, biologics, & drug delivery
Amgen Biosimilars @AmgenBiosim
9K Followers 100 Following This account has joined @Amgen. Follow us there to learn more about biosimilars.
DM Biosimilars @DMBiosimi
400 Followers 134 Following Tweets from Giles Somers up until end March 2015
BiosimilarsIP @BiosimilarsIP
189 Followers 6 Following Authored by @rothwellfiggIP, https://t.co/dhq3Yuz1Jh covers news and provides updates and analyses related to #biologics and #biosimilars under the #BPCIA.
biosimilars @biosims
344 Followers 67 Following The definitive source for news and information on Biosimilars. Stay up-to-date and informed.
AmerisourceBergen Adv.. @Advocacy_ABC
504 Followers 988 Following United in our responsibility to create healthier futures, we are committed to advocating on behalf of our customers and their patients.
Exon 20 Group, a mult.. @Exon20Group
2K Followers 4K Following Global org: patients/carers, HCPs, pharma, labs, scientists, working to cure #NSCLC #HER2 & #EGFR #Exon20 insertions (in 25 cancers +) [email protected]
Total BioPharma @totalbiopharma
2K Followers 1K Following World Drug Safety Congress EU: 9-10 October 2024 World EPA Congress EU: 5-6 March 2025 (https://t.co/2rXow4HNcf)
Matt Massich, PhD @MassichMatt
30 Followers 230 Following Biologist | Biosimilars | Biologics | Pharma | Biotech
Prateek Yadav @iprateekphysio
59 Followers 36 Following Biopharma Consultant, Physiotherapist and certified yoga trainer.All views are personal. Interested in #biosimilar developments of the world
MMIT Network @MMITNetwork
1K Followers 1K Following Our patient-centric mission: At MMIT, we work every day to help patients gain access to lifesaving treatments.
Celltrion @Celltrioninc
253 Followers 282 Following We go beyond to deliver breakthrough therapies and transform the lives of our patients. #DaringtoGoBeyond For guidelines: https://t.co/c3RHkycrT5
Biosimilars and pharm.. @BiosimilarsP
14 Followers 163 FollowingSeniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why? "Despite overall prices for generic medicines continuing to drop, Avalere's analysis shows that prices paid by seniors in Medicare plans continue to increase due to health plans moving generics…
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why? In Medicare Part D, medicines are covered on formulary tiers. A drug on a lower tier will have a lower copay. The average copay charged by health plans is $0 for preferred generics on Tier 1,…
As @IQVIA_global research shows #PBMs cheat U.S. patients and plans out of $6 billion in biosimilars, @BiosimsCouncil Executive Director Craig Burton makes clear: "It is critical that Congress enact legislation to rein in such PBM abuses.” buff.ly/3vNgMeH
Biosimilar competition challenges 11% of total biologic sales, while biosimilar efficiency stands at an impressive 24%. Dive deeper into these insights in our comprehensive report: bit.ly/4cF4wO1. #Biosimilars
Warped incentives update: Humira retains 99% of market share, despite being more expensive than #biosimilars. #PBMs & specialty #pharmacies both benefit from retaining higher-cost #drug. 🙄 Great report from @BiosimsCouncil & @IQVIA_global ==> drugch.nl/3TGDw84
A study by @IQVIA on adalimumab biosimilar savings found billions of dollars in lost opportunities in 2023, primarily because of #PBM incentives to block #biosimilar use. #PBMs #biosimilars #biosimilarsCouncil wp.me/p7gt6c-7qw
.@AccessibleMeds released a report touting the lasting benefits the generic drug industry has provided to patients, employers and taxpayers in the 40 years. ow.ly/IN0a50Qzltx
Congratulations to Rob Albert on his appointment to CEO of B. Braun of America Inc. 🎉prn.to/3vS6OZm
#DYK biosimilars offer a great opportunity to lower patient out-of-pocket costs? Check out the Biosimilars for Employer Consultants 2-pager to discover the value of #biosimilars & how to use them to maximize their value for clients. bit.ly/3Fkirtz #GlobalBiosimilarsWeek
It's #GlobalBiosimilarsWeek! This year's campaign focuses on making cancer care more accessible to patients and healthcare systems. Apotex remains committed to making a difference in the lives of countless patients by fostering access to #biosimilars. lnkd.in/dDDCRmN8
Take this educational curriculum covers the science and regulatory requirements for biosimilars and originator biologics and emerging biosimilars in the MS field ➡️ ms.spr.ly/6013iEV0L #GlobalBiosimilarsWeek #MedEd #MedTwitter
What is the value of #biosimilars for patients? They increase #access to biological treatments and reduce patients’ waiting time to be treated. #GlobalBiosimilarsWeek #BiosimilarEducation @EMA_News @EU_Health @medicinesforEU @WHO Learn more at 👉…imilars.education.digestivecancers.eu
Thank you for joining this year’s #GlobalBiosimilarsWeek ! Tune in to @Igba & our channels if you want follow all updates on #BIosimilarMedicines until #GBW24 ! #GBW23 🧪globalbiosimilarsweek.org/2022/
#GlobalBiosimilarsWeek is a way to discover how #BiosimilarMedicines are 🏥creating sustainable healthcare systems for future generations 💡 fostering innovation Join the movement and discover more! bit.ly/GlobalBiosimil…
More than 10 million people died of cancer in 2020 – 70% in low and middle-income countries. The WHO forecasts that the majority of cancer deaths will continue in LMICs during the next 10yrs. Increasing to access to cancer medicines will save lives. #GlobalBiosimilarsWeek
As we come to a close on #GlobalBiosimilarsWeek, check out our 3-part series exploring how oncology biosmilars are being used in different global markets. Check out Part 1 here: centerforbiosimilars.com/view/part-1-on…
Biosimilar medicines are used to treat brain, breast, cervical, colorectal, kidney, lunch and stomach cancers, as well as non-Hodgkin lymphoma. Currently, there are more than 800 biosimilars approved in 10 therapeutic areas globally. #GlobalBiosimilarsWeek
#GlobalBiosimilarsWeek is a way to discover how #BiosimilarMedicines are: 🏥 creating sustainable health care systems for future generations 💡 fostering innovation Join the movement and discover more! bit.ly/GlobalBiosimil…
❓ Did you know that a biologic drug can undergo hundreds of authorized changes in its lifetime? #GlobalBiosimilarsWeek #MedEd #CME ➡️ ms.spr.ly/6010iDW2C
With oncology biologic medicines projected to expand to 100 new treatments over 5 years, it's crucial to foster conducive biosimilar medicines use policies at the time of IP protection expiry to ensure competition contributes to reduction of treatment costs #GlobalBiosimilarsWeek
Trends for United States
You might like
